Resveratrol in the second half of 11 years or turning point

Business club, January 20 news: the international market in 2009 attracted many plant extract manufacturers to enter the field of resveratrol, but 2010 was disappointing 2009 is a year of resveratrol The prosperity of international market procurement has attracted many plant extract manufacturers to step into the field of resveratrol, and they have high hopes for the future market of resveratrol However, the good times are not long The demand time of resveratrol in 2010 is not as long as expected, but the whole year is in a weak state In addition, Polygonum cuspidatum has always been operating at a high price Currently, more than 60 domestic manufacturers only insist on production, and they are cautiously optimistic about the market in 2011 In 2010, the international market was still dominated by the United States However, the research on resveratrol and the development of new supplements were not as fast as in 2009 However, a lot of new research on resveratrol has been released gradually, which still conveys the message to the industry that it still keeps the market waste heat In 2010, the research of Resveratrol by global scientific research institutions included: the research of resveratrol in the United States can enhance memory, help vision recovery, can be used for weight control and improve memory; the research progress of resveratrol in the United Kingdom can promote blood circulation in the brain; the discovery of Western class teeth that resveratrol can alleviate colitis; the research of Denmark that resveratrol is beneficial to obesity The research of metabolism and the expansion of resveratrol terminal application in Europe and America However, from the perspective of effect, these researches are also weak in promoting resveratrol market On the market side, the launch of fluxome's resveratrol products on US radio has greatly boosted consumer confidence In addition, biotivia Biosciences, the manufacturer and distributor of supplements products in the United States, launched resveratrol supplements listed in the United States, and GNC launched longevity factor series products, which also brought a little vitality to the supplement market in the United States, and made the suppliers of resveratrol raw materials in 2010 see a glimmer of hope Driven by the well-known supplements companies in the United States, resveratrol supplements still occupy a certain position in the sales list in 2010, which shows that this product concept is more popular In the fields of food and cosmetics, products such as juice fortified with resveratrol and resveratrol anti-aging drinking water were launched on the market; some cosmetics companies in the United States and France began to seek resveratrol anti wrinkle formula, and increased sales in the market According to the plant extraction industry information network, resveratrol health ingredients are still regarded as a rising star in the United States in recent years But bad news comes with it With the news that many large pharmaceutical companies' blockbuster drugs have been removed from the shelves, pharmaceutical companies reevaluate and carefully review the clinical trials currently in progress GlaxoSmithKline (GSK) has preliminarily determined that resveratrol srt501 can only play a "minimal role" in renal failure after several months of research The side effects of rt501 in clinical manifestations are nausea, vomiting and diarrhea It is believed that this may indirectly lead to dehydration of the human body and produce renal failure After comprehensive consideration and data analysis, GSK executives decided to terminate srt501 phase II clinical treatment in advance On the last day of November 2010, GSK executives made the latest decision: officially terminate the clinical work of resveratrol drug srt501 previously conducted by the company This is the most suck news for 2010 GSK's SRT501 clinical trials are not only expected by our country's natural resveratrol manufacturers, but also carrying the expectation of synthetic resveratrol manufacturers, hoping to rely on the sale of blockbuster drugs to drive the demand for raw materials into foam This means that in the future, resveratrol will only be used as a supplement In 2009, the price war broke out in China, resveratrol became an eye-catching product in the industry, and a series of production procedures such as large-scale investment attraction, purchase of equipment, and purchase of factory buildings were staged one after another However, in 2010, the exposed resources of Polygonum cuspidatum were over harvested, the quality decreased, the cost of enterprise extraction increased, and the market supply exceeded the demand, which made many follow-up enterprises complain incessantly Finally, under the pressure of a large number of funds being occupied and the depressed market, many enterprises had to leave resveratrol market and seek other ways In 2010, resveratrol fell into the helpless situation of competing low price for enterprise inventory Throughout 2010, the market price of resveratrol in various specifications decreased every month At the peak of 2009, 98% of the transaction price of resveratrol could reach 4600 yuan / kg, but in 2010, the price was more than half lower than that of the same period last year Due to the pressure of market competition, many enterprises have different levels of quotation, "price war" is still the magic weapon of our competitors in the fierce competition of extract market At present, the price of resveratrol has been kept at about 2100 yuan / kg, which is close to the minimum accepted by enterprises On the eve of the Spring Festival, the resveratrol market is basically in the coldest period of the year, and the price also hurts the hearts of the industry people like the cold With the increase of purchase price of wild Polygonum cuspidatum, low price resveratrol will obviously face more and more severe challenges According to the plant extraction industry information network, many domestic active manufacturers are actively contacting the domestic market that can develop resveratrol as a health ingredient to expand the market However, in China, resveratrol still needs a period of time to develop into supplements and functional components The shortage of wild Polygonum cuspidatum resources is increasingly prominent Domestic enterprises in Sichuan and Fujian have considered the problem of artificial cultivation of Polygonum cuspidatum It is understood that the cultivation effect of Polygonum cuspidatum in Fujian is not very ideal; some enterprises in Sichuan are cooperating with relevant domestic research institutions to develop and research the cultivation of Polygonum cuspidatum, which has achieved basic success from soil, breeding, cultivation to the early detection stage However, for the reasons of technology, supply of wild resources and cost of cultivation, enterprises have not considered large-scale cultivation in farmers Polygonum cuspidatum belongs to the perennial plant, the most reasonable growth time is 3 years There is a certain risk in both farmers' planting and production enterprises' construction of planting base Therefore, more time and publicity are needed in the promotion and planting of Polygonum cuspidatum It is expected that the resveratrol market will turn a little better after 2011 than this year, but large-scale cultivation of Polygonum cuspidatum is still unrealistic, which will be a big constraint In 2010, the total output of Polygonum cuspidatum is no more than 10000 tons The annual total output of more than 20 resveratrol manufacturers in China is about 30 tons, with an average monthly output of 1.5 tons per year According to the minimum yield of 15:1, it is estimated that 15000 tons of Polygonum cuspidatum will be needed for 10 consecutive months of production But the market is not able to supply In fact, affected by the continuous decline of resveratrol market this year, many manufacturers have only a few hundred kilograms of Polygonum cuspidatum in stock, and few can achieve continuous production The turning point in 2011 is expected to be a year of adjustment in China's resveratrol market In many manufacturers' cautious expectation, after the digestion from 2010 to the first half of 2011, it will be improved after the second half of 2011 Although the demand for resveratrol in the international market is relatively stable, the international market has not given up the development and research of resveratrol On the premise that the development and sales performance of resveratrol based supplements is satisfactory, the future market of resveratrol is still worth looking forward to.